Ichnos Glenmark Innovation

News

AbbVie has signed another deal in its effort to build an industry-leading position in multispecific antibodies for blood cancers.

News

Chiesi has boosted its rare disease business with an agreement to buy KalVista and Ekterly, its oral drug for treating attacks in rare disease HAE.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.